![Terry Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Terry Evans
Corporate Officer/Principal bij
FENNEC PHARMACEUTICALS INC.
Vermogen: 204 329 $ op 31-07-2026
Profiel
Terry Evans currently works at Fennec Pharmaceuticals, Inc., as Chief Commercial Officer from 2024.
Mr. Evans also formerly worked at Unite Pharma Trade Advisors, as Chief Executive Officer and Currax Pharmaceuticals LLC, as Chief Operating Officer.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-08-2026 | 21.351 ( 0,06% ) | 204 329 $ | 31-07-2026 |
Actieve functies van Terry Evans
| Bedrijven | Functie | Begin |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Corporate Officer/Principal | 28-10-2024 |
Eerdere bekende functies van Terry Evans
| Bedrijven | Functie | Einde |
|---|---|---|
Currax Pharmaceuticals LLC
 Currax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops medicines | Operationeel Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
10
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Fennec Pharmaceuticals, Inc.
 Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
Currax Pharmaceuticals LLC
Currax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
